Menu
HPS2-THRIVE randomized placebo-controlled trial

HPS2-THRIVE randomized pl…

The cardiovascula...

Wake-up call for sleep related CVD risk

Wake-up call for sleep re…

Geneva, Switzerland ...

Commentary regarding the angioplasty and stent of President George W. Bush

Commentary regarding the …

Commentary from T...

Benefit of Eating Fish in Women with CVD risk

Benefit of Eating Fish in…

Dr Marin Strom, from...

Commentary: Omega 3 Trial data release in NEW England Journal Of Medicine

Commentary: Omega 3 Trial…

Written By:  Wi...

Clinical Application of Plasma Sterols/Stanol Measurements

Clinical Application of P…

This lecture is ...

CETP Inhibitor Dalcetrapib Terminated by Roche / Genentech

CETP Inhibitor Dalcetrapi…

Pharmaceutical gi...

Prev Next
Sterol Biomarker Testing-What the Practitioner Needs to Know

Sterol Biomarker Testing-What the Practitioner Needs to Know

This short and succinct lecture offers a current discussion on using markers of cholesterol absorption and synthesis in the clinic. It was presented at the prestigious Baptist International Symposium on Prevention of Cardiovascular Disease in...

Latest Lectures

Genetics and Genomics: Part 2

Genetics and Genomics: Part …

Genetics and Genomics are rapidly changing the way medicine is practiced...

The Ying and Yang of Lipid-modifying agents: CETP Inhibitors

The Ying and Yang of Lipid-m…

The Ying and Yang of Lipid-modifying agents: CETP Inhibitors - are they on li...

Why We Get Fat: Adiposity 101 and the Alternative Hypothesis of Obesity

Why We Get Fat: Adiposity 10…

An intriguing perspective of why we get fat, the growing obesity epidemi...

Sterol Biomarker Testing-What the Practitioner Needs to Know

Sterol Biomarker Testing-Wha…

This short and succinct lecture offers a current discussion on using mar...

More Lectures!